Conventional and Genetic Evidence on Alcohol and Vascular Disease Etiology
Study Questions:
Is there a relationship between cardiovascular (CV) risk and genotype-predicted mean alcohol intake in men and women?
Methods:
The prospective China Kadoorie Biobank enrolled 512,715 adults between June 25, 2004, and July 15, 2008, from 10 areas of China, and recorded data associated with atherosclerotic CV disease (ASCVD). Follow-up for about 10 years included monitoring for CVD (ischemic stroke, intracerebral hemorrhage, and myocardial infarction [MI]) by linkage with morbidity and mortality registries and electronic hospital records. A total of 161,498 participants were genotyped for two variants that alter alcohol metabolism and reduce use, ALDH2-rs671 and ADH1B-rs1229984. Adjusted Cox regression was used to obtain the relative risks (RRs) associating disease incidence with self-reported drinking patterns (conventional epidemiology) or with genotype-predicted mean male alcohol intake (genetic epidemiology, i.e., Mendelian randomization), with stratification by study area to control for variation between areas in disease rates and in genotype-predicted intake.
Results:
Mean age was 52 years (standard deviation, 11 years), 33% of men reported drinking alcohol in most weeks, mainly as spirits, compared with only 2% of women with wide variation among study areas. Among men, conventional epidemiology showed that self-reported alcohol intake had U-shaped associations with the incidence of ischemic stroke, intracerebral hemorrhage, and MI; men who reported drinking about 100 g of alcohol per week (1-2 drinks per day) had lower risks of all three diseases than nondrinkers or heavier drinkers. In contrast, although genotype-predicted mean male alcohol intake varied widely (from 4 to 256 g per week, i.e., near zero to about four drinks per day), it did not have any U-shaped associations with risk. For stroke, genotype-predicted mean alcohol intake had a continuously positive log-linear association with risk, which was stronger for intracerebral hemorrhage (RR per 280 g per week, 1.58; p < 0.0001) than for ischemic stroke (1.27; p = 0.0001). For MI, however, genotype-predicted mean alcohol intake was not significantly associated with risk. Usual alcohol intake in current drinkers and genotype-predicted alcohol intake in all men had similarly strong positive associations with systolic blood pressure (each p < 0.0001). Among women, few drank, and the studied genotypes did not predict high mean alcohol intake and were not positively associated with blood pressure, stroke, or MI.
Conclusions:
Genetic epidemiology shows that the apparently protective effects of moderate alcohol intake against stroke are largely noncausal. Alcohol consumption uniformly increases blood pressure and stroke risk, and appears in this one study to have little net effect on the risk of MI.
Perspective:
Moderate alcohol intake has been associated with reduced ASCVD in many cohort studies of European descent and thought to be CV protective even in persons with treated hypertension. This study was only possible because of the unique presence of two genetic variants in east Asians that either reduce alcohol intake by very slow or very fast metabolism, which results in toxic symptoms or minimal effects. The excess risk of ischemic stroke was 27% and 58% for intracerebral hemorrhage per 280 g alcohol per week (average being about 250 g per week). In the United States (US), the moderate alcohol average is about 100 g per week. I do not think this study is applicable to the US, considering that in a 2018 study, it was much lower than the US. Overall, 23.2% of the Chinese adult population had hypertension defined as 140/90 mm Hg, and the risk factors of smoking, physical activity, air pollution, diet, diabetes, and obesity differ considerably.
Clinical Topics: Cardiovascular Care Team, Prevention, Hypertension
Keywords: Alcohol Drinking, Alcoholic Beverages, Atherosclerosis, Blood Pressure, Brain Ischemia, Cerebral Hemorrhage, China, Genotype, Hypertension, Myocardial Infarction, Primary Prevention, Stroke, Vascular Diseases
< Back to Listings